In contrast to homozygous GlyT2-deficient mice that die in the second postnatal week, in adult human hyperekplexia patients, only a relatively mild hyperreflexia persists that in most cases does not need therapeutic intervention [94]; this has been observed for both GlyR and GlyT2 mutations. The gene discussed is SLC6A5; the disease is hyperekplexia.